A recent study revealed that tumor‐initiating cells specifically recruit tumor‐promoting neutrophils via the CXCL2‐CXCR2 axis and create an immunosuppressive TME in hepatocellular carcinoma, supporting our findings.[39]. This evidence concerns the gene CXCL2 and hepatocellular carcinoma.